Associate Director, Commercial Finance

Job description

The Associate Director, Commercial Finance will manage the company’s Commercial Finance activities and serve as a key finance partner to the Commercial organization. The role will support the company’s commercial products, including QINLOCK and ROMVIMZA, while helping prepare the organization for multiple product launches planned over the next several years. This individual will oversee revenue forecasting and reporting, gross-to-net, budgeting and forecasting, long-range planning, commercial investment analysis, launch planning and performance analysis. The Associate Director will work closely with Commercial and Finance stakeholders to provide actionable insights supporting business decisions and will manage and develop the Commercial Finance team. This is a hands-on role with regular interaction across Deciphera and corporate headquarters. The successful candidate will bring strong biopharmaceutical Commercial Finance experience together with analytical, business partnering, communication and people management skills. Key Responsibilities: Commercial Finance Leadership and Business Partnership 100% Serve as a key Finance partner to the Commercial organization, providing analysis, guidance and insights to support strategic and operational decision-making. Manage Commercial financial planning activities, including annual budgeting, forecasts, long-range planning and ongoing performance analysis. Oversee revenue forecasting and performance reporting, including analysis of actual results against forecast and guidance. Partner closely with Accounting and Commercial stakeholders on revenue recognition, gross-to-net assumptions and reporting, including government rebates, returns reserves and other adjustments to revenue. Provide financial analysis and decision support for current and future product launches, including scenario planning, investment decisions, resource allocation and assessment of post-launch performance. Partner with Commercial leadership and functional teams, including Sales, Marketing, Market Access and Commercial Operations, on financial and strategic initiatives, including pricing dynamics and contract administration. Prepare and deliver key financial analyses and presentations to Commercial and Finance leadership and corporate headquarters, including support for earnings and other management reporting. Collaborate with cross-functional partners through the S&OP process to align commercial forecasts with supply planning and ensure continuity of supply. Lead, coach and develop members of the Commercial Finance team, fostering strong business partnership, analytical capabilities and professional development. Manage special projects and analyses that bring a financial and analytical perspective to decision-making and drive continuous improvement. Other duties and responsibilities as assigned Bachelor’s degree in Finance, Accounting, Economics, Business Administration, or a related field. Minimum of 8 years of relevant Finance experience, including meaningful Commercial Finance, FP&A, or related experience within the biopharmaceutical or pharmaceutical industry. Strong understanding of pharmaceutical commercialization and key financial drivers, including revenue forecasting, gross-to-net, operating expense management, and financial planning and analysis. Experience partnering with Commercial stakeholders and providing financial analysis and insights to support business decisions. Demonstrated people leadership skills, including experience managing and developing Finance professionals. Excellent analytical, financial modeling, communication, and presentation skills, including the ability to communicate effectively with business leaders and corporate headquarters. Preferred Capabilities Experience supporting commercial product launches and/or products at various stages of commercialization. Proven ability to develop and implement scalable, “right-sized” financial processes in a growing or evolving organization. Strong strategic thinking and problem-solving skills, with the ability to develop financial frameworks and scenario analyses to support complex business decisions. Ability to operate effectively in a fast-paced, evolving environment, balancing strategic priorities with hands-on execution and changing business needs. Strong relationship-building and influencing skills, with a demonstrated ability to collaborate effectively across Finance and Commercial functions and at all levels of the organization. Deciphera is committed to fair and equitable compensation practices. The base salary pay range for this role is $176,000-$215,000. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location.​ Deciphera believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Deciphera’s competitive total rewards strategy that also includes annual performance bonus, a long-term incentive plan, full range of benefits and other incentive compensation plans (if applicable) Benefits: Competitive salary and annual bonus. Comprehensive benefits package including medical, dental, vision insurance, 401(k) retirement plan with company match, and more. Generous parental leave and family planning benefits. Outstanding culture and opportunities for personal and professional growth. EQUAL EMPLOYMENT OPPORTUNITY INFORMATION Deciphera is committed to equal employment opportunity and values diversity. To ensure that we comply with reporting requirements, we invite you complete the confidential survey at the end of this application. Providing this information is optional. It will not be accessible or used in the hiring process, and has no effect on your opportunity for employment. This information will also be treated confidentially. We are committed to make all hiring decisions and other employment decisions on a non-discriminatory basis. Deciphera, a member of Ono Pharmaceutical Co., Ltd., is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines and providing hope to people living with cancer, neurologic and autoimmune disease. Deciphera is leveraging its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from Deciphera’s platform in clinical studies, QINLOCK® (ripretinib) is Deciphera’s switch-control kinase inhibitor approved in many countries including the European Union and the United States for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib. ROMVIMZA® (vimseltinib) is a kinase inhibitor approved in the United States for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity, and in the European Union for adult patients with TGCT associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability. The spirit of collaboration that has brought medications to life continues to guide how we operate, grow, and discover new breakthroughs. We cultivate an inclusive culture that values curiosity, creativity, and shared accountability—empowering individuals to challenge the unknown together. Deciphera offers competitive compensation, including equity-based compensation, and a comprehensive benefits package that includes medical, dental, vision, 401(k) retirement plan, life insurance and a flexible spending account for either health care and/or dependent care.